AGREEMENT AND PLAN OF MERGER by and among STIEFEL LABORATORIES, INC., BENGAL ACQUISITION INC. and BARRIER THERAPEUTICS, INC. Dated as of June 23, 2008Merger Agreement • July 8th, 2008 • Stiefel Laboratories, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 8th, 2008 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”) is entered into as of June 23, 2008, by and among Stiefel Laboratories, Inc. (“Parent”), a Delaware corporation, Bengal Acquisition Inc. (“Purchaser”), a Delaware corporation and direct wholly-owned subsidiary of Parent, and Barrier Therapeutics, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER among SMITHKLINE BEECHAM CORPORATION, FOUNTAIN ACQUISITION CORPORATION and SIRTRIS PHARMACEUTICALS, INC. Dated as of April 22, 2008Merger Agreement • May 2nd, 2008 • Glaxosmithkline PLC • Pharmaceutical preparations • Delaware
Contract Type FiledMay 2nd, 2008 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER, dated as of April 22, 2008 (this “Agreement”), among SmithKline Beecham Corporation, a Pennsylvania corporation (“Parent”), Fountain Acquisition Corporation, a Delaware corporation and wholly-owned Subsidiary of Parent (“Purchaser”), and Sirtris Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER among SMITHKLINE BEECHAM CORPORATION, FOUNTAIN ACQUISITION CORPORATION and SIRTRIS PHARMACEUTICALS, INC. Dated as of April 22, 2008Merger Agreement • April 23rd, 2008 • Sirtris Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 23rd, 2008 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER, dated as of April 22, 2008 (this “Agreement”), among SmithKline Beecham Corporation, a Pennsylvania corporation (“Parent”), Fountain Acquisition Corporation, a Delaware corporation and wholly-owned Subsidiary of Parent (“Purchaser”), and Sirtris Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER Dated as of February 25, 2008 among Galderma Laboratories, Inc., Galderma Acquisition Inc. and CollaGenex Pharmaceuticals, Inc.Merger Agreement • March 10th, 2008 • Galderma Laboratories, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 10th, 2008 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of February 25, 2008 (this “Agreement”), is among Galderma Laboratories, Inc., a Delaware corporation (“Parent”), Galderma Acquisition Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Purchaser”), and CollaGenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Certain terms used in this Agreement without definition shall have their meanings as defined in Section 8.11.
AGREEMENT AND PLAN OF MERGER Dated as of February 25, 2008 among Galderma Laboratories, Inc., Galderma Acquisition Inc. and CollaGenex Pharmaceuticals, Inc.Merger Agreement • February 27th, 2008 • Collagenex Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 27th, 2008 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of February 25, 2008 (this “Agreement”), is among Galderma Laboratories, Inc., a Delaware corporation (“Parent”), Galderma Acquisition Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Purchaser”), and CollaGenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Certain terms used in this Agreement without definition shall have their meanings as defined in Section 8.11.
AGREEMENT AND PLAN OF MERGER dated as of June 28, 2007 by and among infoUSA Inc., Knickerbocker Acquisition Corp. and Guideline, Inc.Merger Agreement • July 5th, 2007 • Infousa Inc • Services-direct mail advertising services • New York
Contract Type FiledJuly 5th, 2007 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 28, 2007, is entered into by and among infoUSA Inc., a Delaware corporation (“Parent”), Knickerbocker Acquisition Corp., a New York corporation and a wholly-owned subsidiary of Parent (“Purchaser”), and Guideline, Inc., a New York corporation (the “Company”).
AGREEMENT AND PLAN OF MERGER by and among CYTYC CORPORATION (“Parent”) AUGUSTA MEDICAL CORPORATION (“Purchaser”) and ADEZA BIOMEDICAL CORPORATION (the “Company”) Dated as of February 11, 2007Merger Agreement • February 12th, 2007 • Adeza Biomedical Corp • Instruments for meas & testing of electricity & elec signals • Delaware
Contract Type FiledFebruary 12th, 2007 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER (hereinafter referred to as this “Agreement”), dated as of February 11, 2007 by and among Cytyc Corporation, a Delaware corporation (“Parent”), Augusta Medical Corporation, a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Purchaser”), and Adeza Biomedical Corporation, a Delaware corporation (the “Company”).